RWIBX
Price
$80.66
Change
-$0.06 (-0.07%)
Updated
Jun 22 closing price
Net Assets
159.53B
SMYSX
Price
$30.76
Change
-$0.05 (-0.16%)
Updated
Jun 22 closing price
Net Assets
637.94M
Interact to see
Advertisement

RWIBX vs SMYSX

RWIBX vs SMYSX Comparison Chart in %
View a ticker or compare two or three
VS
RWIBX vs. SMYSX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Hold and SMYSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 160B vs. SMYSX (638M). SMYSX (0.77) and RWIBX (0.74) have matching dividends . RWIBX was incepted earlier than SMYSX: RWIBX (24 years) vs SMYSX (7 years). RWIBX (1.51) is less costly to investors than SMYSX (0.83). RWIBX is a more actively managed with annual turnover of: 44.00 vs. SMYSX (31.00). RWIBX has a lower initial minimum investment than SMYSX: RWIBX (250) vs SMYSX (1000000). SMYSX annual gain was more profitable for investors over the last year : 21.31 vs. RWIBX (17.83). SMYSX return over 5 years is better than : 56.53 vs. RWIBX (27.84).
RWIBXSMYSXRWIBX / SMYSX
Total Expense Ratio1.510.83182%
Annual Report Gross Expense Ratio1.510.83182%
Fund Existence24 years7 years-
Gain YTD13.0179.800133%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets160B638M25,078%
Annual Yield % from dividends0.740.7797%
Returns for 1 year17.8321.3184%
Returns for 3 years46.7374.9562%
Returns for 5 years27.8456.5349%
Returns for 10 years98.11N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPSX44.07N/A
N/A
ProFunds Biotechnology UltraSector Svc
TSVRX22.11N/A
N/A
PGIM Quant Solutions Small-Cap Val R
ACAYX66.15N/A
N/A
Alger Capital Appreciation Instl Y
FIJCX89.83N/A
N/A
Fidelity Advisor Consumer Staples Z
DFIEX22.01-0.42
-1.87%
DFA International Core Equity 2 I